DRUG_NAME,STRUCT_ID,TARGET_NAME,TARGET_CLASS,ACCESSION,GENE,SWISSPROT,ACT_VALUE,ACT_UNIT,ACT_TYPE,ACT_COMMENT,ACT_SOURCE,RELATION,MOA,MOA_SOURCE,ACT_SOURCE_URL,MOA_SOURCE_URL,ACTION_TYPE,TDL,ORGANISM,NEW_ID
(S)-nicardipine,5,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,8.4,,IC50,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,IUPHAR,=,1.0,IUPHAR,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251230,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1391
(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1393
(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:2245
(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q02485,Cacna1s,CAC1S_RAT,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:70983
(S)-nitrendipine,6,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin,Homo sapiens,HGNC:1390
phenylbutanoic acid,24,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.19,,IC50,Inhibition of human recombinant HDAC2,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:4853
acepromazine,73,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.3,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9449
adiphenine,94,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.45,,Kd,Affinity for the Muscarinic acetylcholine receptor,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
alcuronium,109,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.0,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
alcuronium,109,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
amitriptyline,180,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.83,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
amitriptyline,180,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,6.52,,IC50,Inhibition of radioligand [3H]QNB binding to muscarinic acetylcholine receptor in the rat forebrain in the presence of zinc,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
amlodipine,183,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,BLOCKER,Tclin,Homo sapiens,HGNC:1390
amlodipine,183,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,7.0,,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,BLOCKER,Tclin,Homo sapiens,HGNC:1391
amlodipine,183,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,8.7,,Ki,Binding affinity against rat L-type calcium channel,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
amodiaquine,186,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,5.4,,IC50,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
amoxapine,191,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.542,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
octatropine methylbromide,223,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,DRUGBANK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1578,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
aprindine,231,Sodium/calcium exchanger 1,Transporter,P32418,SLC8A1,NAC1_HUMAN,4.301,,IC50,,WOMBAT-PK,=,,,,,,Tbio,Homo sapiens,HGNC:11068
aranidipine,234,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D01562,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
atracurium,259,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.77,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1360,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
azathioprine,269,Ras-related C3 botulinum toxin substrate 1,Enzyme,P63000,RAC1,RAC1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tbio,Homo sapiens,HGNC:9801
azelastine,271,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.2,,IC50,Displacement of [3H]AF-DX 384 from recombinant human M1 receptor expressed in CHO cells,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
azelnidipine,272,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D01145,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
barnidipine,290,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D07494,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
bendamustine,302,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,8.05,,IC50,,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:4853
bendroflumethiazide,305,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:6284
diphenidol,313,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.108,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL936,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
benzthiazide,332,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:6284
benzatropine,333,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.636,,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201203,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
benzatropine,333,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.23,,Ki,Displacement of [3H]pirenzepine binding at Muscarinic acetylcholine receptor M1 in rat brain P2 membranes.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
biperiden,374,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.32,,Kd,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1101,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
bromperidol,407,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.119,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
scopolamine butylbromide,458,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
cadralazine,461,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
caramiphen,486,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.92,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
pentoxyverine,494,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.12,,Ki,Binding affinity towards muscarinic m1 receptor,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
carvedilol,522,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4.52,,IC50,,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
cevimeline,584,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.638,,EC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL168815,AGONIST,Tclin,Homo sapiens,HGNC:1950
chloropyramine,606,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.24,,Kd,Binding affinity to biotinylated human FAK FAT domain by biolayer interoferometry,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
chlortetracycline,624,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,,,,,WOMBAT-PK,,,,,,,Tchem,Homo sapiens,HGNC:9449
chlorzoxazone,626,"Nitric oxide synthase, brain",Enzyme,P29475,NOS1,NOS1_HUMAN,4.3,,IC50,Inhibitory activity against Neuronal nitric oxide synthase,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:7872
chlorzoxazone,626,"Nitric oxide synthase, brain",Enzyme,P29476,Nos1,NOS1_RAT,5.554,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",DRUG MATRIX,=,,,,,,,Rattus norvegicus,RGD:3184
chlorzoxazone,626,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,4.523,,EC50,Chlorzoxazone-stimulated activity of BK(Ca) channels in neuroblastoma IMR-32 cells,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/12480161,https://pubmed.ncbi.nlm.nih.gov/12480161,OPENER,Tclin,Homo sapiens,HGNC:6284
cilnidipine,642,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/9298526,https://pubmed.ncbi.nlm.nih.gov/9298526,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
cinnarizine,654,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.218,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
cisatracurium,661,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,8.0,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201248,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
clemastine,671,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.796,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
clevidipine,674,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132,BLOCKER,Tclin,Homo sapiens,HGNC:1390
clevidipine,674,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132,BLOCKER,Tclin,Homo sapiens,HGNC:1391
clidinium,676,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL620,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
clotiapine,717,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,6.87,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
colforsin daropate,729,Adenylate cyclase type 1,Enzyme,Q08828,ADCY1,ADCY1_HUMAN,7.39,,IC50,Inhibition of [125 I]6-IHPP-forskolin binding to adenylate cyclase 1,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:232
cyamemazine,746,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.886,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
cyclizine,749,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.788,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
cyclobenzaprine,751,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.95,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
cycrimine,763,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201227,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
darifenacin,784,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.3,,Ki,GRAC: human M1 antagonist,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
decamethonium,789,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1190,PARTIAL AGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
desloratadine,814,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.74,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
dexetimide,831,Muscarinic acetylcholine receptor,GPCR,P12657|P32211|Q920H4|Q9ERZ3|Q9ERZ4,Chrm1|Chrm4|Chrm5|Chrm3|Chrm2,ACM1_MOUSE|ACM4_MOUSE|ACM5_MOUSE|ACM3_MOUSE|ACM2_MOUSE,8.48,,IC50,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to muscarinic receptor in mice,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
dexfenfluramine,832,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.733,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
dicycloverine,868,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.079,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
dicycloverine,868,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.61,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
dimenhydrinate,901,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.963,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
dimetindene,903,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.58,,Ki,,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
dimethyltubocurarinium,908,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.745,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1259,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
diphemanil,915,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201340,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
diphenylpyraline,920,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.699,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
disopyramide,926,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
dosulepin,951,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.744,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
doxepin,956,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.42,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
drotaverine,969,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
droxidopa,971,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.1,,Ki,,IUPHAR,=,,,,,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
droxidopa,971,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.1,,Ki,,IUPHAR,=,,,,,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
efonidipine,992,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
endralazine,1008,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
estramustine phosphate,1066,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.2,,IC50,Inhibition of recombinant PTP1B,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
felodipine,1142,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480,BLOCKER,Tclin,Homo sapiens,HGNC:1390
felodipine,1142,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480,BLOCKER,Tclin,Homo sapiens,HGNC:1391
fenfluramine,1150,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.016,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
fluphenazine enanthate,1214,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.961,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
hexocyclium,1371,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,UNKNOWN,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201325,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
hexocyclium,1371,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.6,,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Rattus norvegicus,RGD:2342
homatropine,1379,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.495,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
hydroxychloroquine,1395,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.81,,Ki,Activity of compound against Muscarinic acetylcholine receptor M1 (CHRM1) by displacement of 3H-QNB,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
hyoscyamine,1402,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.0,,Ki,,WOMBAT-PK,=,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D00147,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
ipratropium,1475,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.31,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
ipratropium,1475,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.54,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M1 receptor in cortex membrane,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
isopropamide,1500,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201232,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
ketorolac,1529,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,4.44,,IC50,Inhibition of PAK1 in human A549 cells using myelin basic protein as substrate preincubated for 24 hrs followed by PAK1 immunoprecipation and substrate addition measured after 60 mins by ATP-Glo kinase assay,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8590
lacidipine,1532,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
levosimendan,1576,"Troponin C, slow skeletal and cardiac muscles",Cytosolic other,P63316,TNNC1,TNNC1_HUMAN,3.155,,Kd,affinity for the binding of levosimendan to cNTnC-Ca2+-cTnI-(144-163) complex,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/18570382,https://pubmed.ncbi.nlm.nih.gov/18570382,OPENER,Tclin,Homo sapiens,HGNC:11943
lidocaine,1579,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,4.955,,IC50,,WOMBAT-PK,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
lofepramine,1592,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.174,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
loxapine,1613,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.26,,IC50,Inhibition of binding of 1.0 nM [3H]pirenzepine to cloned human Muscarinic acetylcholine receptor M1 expressed in membranes from CHO-K1 cells,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
maprotiline,1634,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.845,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
mebhydrolin,1643,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.745,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
pecazine,1688,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.721,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
mepenzolate,1689,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL524004,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
mesoridazine,1712,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.0,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
methacholine,1726,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.638,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
methacholine,1726,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,6.4,,EC50,,IUPHAR,=,,,,,AGONIST,,Rattus norvegicus,RGD:2342
methapyrilene,1738,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.939,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
methscopolamine,1757,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.9,,Ki,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201268,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
methysergide,1775,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.263,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
mibefradil,1797,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.9,,IC50,,IUPHAR,=,,,,,BLOCKER,Tclin,Homo sapiens,HGNC:1390
miltefosine,1810,Dual specificity phosphatase Cdc25A,Enzyme,P30304,CDC25A,MPIP1_HUMAN,4.6,,IC50,Inhibition of Cell division cycle 25 (Cdc25) phosphatase,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:1725
minaprine,1812,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.77,,Ki,Binding affinity towards muscarinic M1 receptor,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
minaprine,1812,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,4.77,,IC50,Displacement of [3H]pirenzepine from cerebral Muscarinic acetylcholine receptor M1,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
mirtazapine,1816,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
mivacurium,1822,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL984,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
montelukast,1836,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.713,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
nilvadipine,1934,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1390
nilvadipine,1934,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1391
nilvadipine,1934,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/7898101,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,UNKNOWN,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,BLOCKER,Tclin,Homo sapiens,HGNC:1390
nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,UNKNOWN,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,BLOCKER,Tclin,Homo sapiens,HGNC:1391
nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1397
nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1393
nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6.8,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:2245
nimodipine,1937,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,6.6,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:70973
nisoldipine,1942,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,7.1,,IC50,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1390
nisoldipine,1942,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,UNKNOWN,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726,BLOCKER,Tclin,Homo sapiens,HGNC:1391
nisoldipine,1942,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q01815,Cacna1c,CAC1C_MOUSE,8.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Mus musculus,MGI:103013
nisoldipine,1942,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q99246,Cacna1d,CAC1D_MOUSE,7.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Mus musculus,MGI:88293
nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,8.4,,IC50,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,IUPHAR,=,1.0,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1391
nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6.0,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,Tclin,Homo sapiens,HGNC:1393
nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:2245
nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q02485,Cacna1s,CAC1S_RAT,6.0,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,Rattus norvegicus,RGD:70983
nitrendipine,1947,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,9.6,,Ki,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,CHEMBL,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin,Homo sapiens,HGNC:1390
nortriptyline,1971,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.398,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
nortriptyline,1971,ATP-sensitive inward rectifier potassium channel 10,Ion channel,P78508,KCNJ10,KCJ10_HUMAN,4.796,,IC50,inhibition at +30 mV,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/17071817,,BLOCKER,Tbio,Homo sapiens,HGNC:6256
ondansetron,1992,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,5.0,,Ki,The binding affinity was measured on muscarine M1 receptor using [3H]- pirenzepine as radioligand.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
orphenadrine,1999,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.39,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
oxyphencyclimine,2026,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200891,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
oxybutynin,2028,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.23,,Ki,Binding affinity for rat cortex muscarinic acetylcholine receptor M1 using [3H]pirenzepine,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
oxybutynin,2028,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.0,,Ki,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M1 receptor expressed in Sf9 cells,CHEMBL,=,1.0,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000532/WC500040171.pdf,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
oxyphenonium,2039,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200906,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
pancuronium,2052,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,8.201,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185073,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
pancuronium,2052,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.09,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
perhexiline,2106,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.185,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
pilocarpine,2166,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,5.51,,Ki,"Compound was evaluated for its affinity towards Muscarinic acetylcholine receptor M1, using [3H]- pirenzepine, a radioligand displacement assay in rat hippocampal membranes",CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
pilocarpine,2166,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,5.16,,EC50,Tested against Muscarinic acetylcholine receptor M1 expressed in A9 L cell line,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
pilocarpine,2166,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.08,,Ki,Inhibition of [3H]OXO-M binding against muscarinic acetylcholine receptor in rat brain membranes,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
pilocarpine,2166,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.02,,EC50,calcium response in CHO cells,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/24558448,,AGONIST,Tclin,Homo sapiens,HGNC:1950
pinacidil,2173,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:6284
pipecuronium,2183,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201206,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
pizotifen,2220,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.7,,Ki,Binding affinity to muscarinic M1 receptor (unknown origin),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
prenylamine,2261,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,6.68,,Kd,Inhibition of [3H]nitrendipine binding to calcium channel of rat brain membranes.,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2245
pridinol,2263,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.796,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
procaine,2271,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,4.342,,IC50,,WOMBAT-PK,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
procyclidine,2276,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.337,,Ki,,PDSP,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86715,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
propantheline,2293,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.7,,Ki,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1180725,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
propiomazine,2298,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
protriptyline,2320,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.7,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
rocuronium,2396,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.77,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200648,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
rocuronium,2396,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.09,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
solifenacin,2457,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.2,,IC50,Displacement of [3H]NMS from human muscarinic M1 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
solifenacin,2457,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.0,,Ki,Binding affinity for rat cortex muscarinic acetylcholine receptor M1 using [3H]pirenzepine,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
strychnine,2484,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.0,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
suxamethonium,2489,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL703,AGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
suloctidil,2536,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.965,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
sapropterin,2612,"Nitric oxide synthase, brain",Enzyme,P29475,NOS1,NOS1_HUMAN,5.95,,Kd,Activity of tetrahydrobiopterin free nNOS,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:7872
thiothixene,2639,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.585,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
tiludronic acid,2666,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tchem,Homo sapiens,HGNC:9642
tiotropium bromide,2677,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,11.0,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
tiotropium bromide,2677,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.8,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M1 receptor in cortex membrane,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
tolterodine,2705,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.85,,Ki,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M1 receptor expressed in CHO cells,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
tolterodine,2705,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.85,,Ki,Displacement of [3H]NMS from muscarinic receptor M1 in Sprague-Dawley rat brain homogenates after 60 mins by liquid scintillation counting method,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
tridihexethyl,2737,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201354,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
trihexyphenidyl,2745,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.89,,IC50,Evaluated for its binding affinity at human muscarinic receptor m1 by displacement of [3H]NMS binding using membranes in transfected chinese hamster ovarian cell,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
troglitazone,2767,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.26,,IC50,Inhibition of PTP1B,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:9642
tropicamide,2774,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.167,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
trospium,2776,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,Tclin,Homo sapiens,HGNC:1950
valethamate,2800,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.56,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
vecuronium,2811,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.824,,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
vecuronium,2811,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.09,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
vinburnine,2824,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.1,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
nicotinic acid,2835,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4.88,,IC50,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
zotepine,2875,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.745,,Ki,,PDSP,=,,,,,,Tclin,Homo sapiens,HGNC:1950
doxacurium,2974,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237099,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
benzethonium,3018,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.004,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
bietamiverine,3025,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.57,,Ki,Displacement of [3H] N-methylscopolamine from human muscarinic M1 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
eburnamonine,3170,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.1,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
femoxetine,3220,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.036,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
furtrethonium,3256,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.1,,Ki,,IUPHAR,=,,,,,AGONIST,Tclin,Homo sapiens,HGNC:1950
rapacuronium,3520,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNG|CHRNB1|CHRNE|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/8680742,ANTAGONIST,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1955
ruboxistaurin,3533,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,5.64,,Kd,Average Binding Constant for MARK2; NA=Not Active at 10 uM,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:3332
sabcomeline,3536,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.77,,IC50,In vitro affinity against human Muscarinic acetylcholine receptor M1 using quinuclidynyl benzylate (QNB),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
sabcomeline,3536,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,7.85,,IC50,In vitro affinity evaluated using [3H]- oxotremorine as radioligand in rat cerebral cortex for muscarinic acetylcholine receptor,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
vincamine,3643,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.8,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,Tclin,Homo sapiens,HGNC:1950
xanomeline,3652,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.38,,Ki,Affinity towards human M1 receptor expressed in CHO cells using [3H]QNB as radioligand,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
xanomeline,3652,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.7,,IC50,Binding affinity for muscarinic acetylcholine receptor M1 using [3H]oxotremorine-M (Oxo-M) radioligand in rat hippocampus membranes,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
xanomeline,3652,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,5.24,,EC50,Tested against Muscarinic acetylcholine receptor M1 expressed in A9 L cell line,CHEMBL,=,,,,,,,Mus musculus,MGI:88396
xanomeline,3652,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,8.01,,IC50,Binding affinity against muscarinic receptor in rat brain membranes using oxotremorine-M as ligand,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
benidipine,3880,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,5.31,,IC50,"Inhibition of human L-type calcium channel Ca<sub>v</sub>1.2 in <i>Xenopus</i> oocyte, measured using 2-electrode voltage-clamp.",IUPHAR,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/17276408,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
levamlodipine,4099,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/17213004,https://pubmed.ncbi.nlm.nih.gov/17213004,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
asenapine,4115,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.107,,Ki,,PDSP,,,,,,,Tclin,Homo sapiens,HGNC:1950
romidepsin,4119,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,7.328,,IC50,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:4853
gentian violet,4138,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.578,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
lercanidipine,4157,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1D|CACNA1C,CAC1D_HUMAN|CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/8821512,https://pubmed.ncbi.nlm.nih.gov/8821512,BLOCKER,Tclin|Tclin|Tclin|Tclin,Homo sapiens,HGNC:1391
vandetanib,4178,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.15,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
crizotinib,4187,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.25,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
crizotinib,4187,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.51,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
fesoterodine,4191,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.393,,Ki,,WOMBAT-PK,=,,,,,,Tclin,Homo sapiens,HGNC:1950
axitinib,4225,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.35,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:16059
Florbetapir F-18,4285,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,8.54,,Ki,,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
Flutemetamol (18F),4301,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,9.15,,Ki,Binding affinity to human amyloid beta plaque,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
glycopyrronium bromide,4302,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.69,,Ki,,SCIENTIFIC LITERATURE,=,1.0,CHEMBL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201027,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
aceclidine,4314,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.0,,EC50,,IUPHAR,=,,,,,AGONIST,Tclin,Homo sapiens,HGNC:1950
aceclidine,4314,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,6.92,,IC50,Binding affinity for muscarinic acetylcholine receptor M1 using [3H]oxotremorine-M (Oxo-M) radioligand in rat hippocampus membranes,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
aceclidine,4314,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm3|Chrm4|Chrm5|Chrm2,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,5.08,,Ki,"Binding affinity against muscarinic acetylcholine receptor from rat brain crude membrane, using [3H]-NMS (N-Methylscopolamine) as the radioligand.",CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
afatinib,4318,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.55,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
dexchlorpheniramine,4411,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.478,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
carfilzomib,4483,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,8.222,,IC50,fluorogenic peptide substrate hydrolysis,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/17616698,https://pubmed.ncbi.nlm.nih.gov/17616698,INHIBITOR,Tclin,Homo sapiens,HGNC:9542
aclidinium bromide,4484,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,10.1,,Ki,Binding affinity to muscarinic M1 receptor,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1950
trabectedin,4633,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.68,,IC50,Inhibition of Src,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
methylatropine,4660,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.6,,Kd,In vitro receptor binding against Muscarinic acetylcholine receptor M1 in rat cerebral cortex was determined using [3H]pirenzepine,CHEMBL,=,,,,,,,Rattus norvegicus,RGD:2342
betamethasone phosphate,4667,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.776,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,Tclin,Homo sapiens,HGNC:1950
cabozantinib,4715,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.75,,IC50,"Inhibition of Src (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
ibrutinib,4810,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.721,,IC50,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/26641137,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
umeclidinium,4816,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.796,,Ki,"radioligand binding assays in CHO cells expressing human M1, M2, or M3 receptors in a scintillation proximity assay with 0.5 nM [3H]-N-methyl scopolamine as the ligand",SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/19317446,,,Tclin,Homo sapiens,HGNC:1950
florbetaben F18,4818,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,8.65,,Ki,,CHEMBL,=,,,,,,,Homo sapiens,HGNC:620
ceritinib,4866,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.77,,IC50,Inhibition of TEL-fused SRC (unknown origin) by cell-based assay,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
imidafenacin,4902,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.384,,Kb,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/10428387,,,Tclin,Homo sapiens,HGNC:1950
chidamide,4973,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,6.796,,IC50,HDAC enzyme inhibition assay using BSA substrate,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/22080169,https://pubmed.ncbi.nlm.nih.gov/22080169,INHIBITOR,Tclin,Homo sapiens,HGNC:4853
ixazomib,5067,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,8.469,,IC50,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/20160034,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208462lbl.pdf,INHIBITOR,Tclin,Homo sapiens,HGNC:9542
eteplirsen,5182,exon 51 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,,,,Mechanism of Action,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf,BINDING AGENT,Tclin,Homo sapiens,HGNC:2928
apatinib,5211,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.276,,IC50,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/21443688,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
neratinib,5252,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.39,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
neratinib,5252,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,5.72,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
neratinib,5252,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,6.68,,Kd,Binding constant for PAK1 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8590
neratinib,5252,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,7.1,,Kd,Binding constant for PAK2 kinase domain,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:8591
dacomitinib,5297,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.96,,IC50,Inhibition of Src (unknown origin),CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
lorlatinib,5302,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,7.77,,IC50,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,Tclin,Homo sapiens,HGNC:9611
revefenacin,5303,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.38,,Ki,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/29736245,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf,ANTAGONIST,Tclin,Homo sapiens,HGNC:1950
selinexor,5330,Exportin-1,Nuclear other,O14980,XPO1,XPO1_HUMAN,7.7,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://clinicaltrials.gov/ProvidedDocs/61/NCT02215161/Prot_SAP_000.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212306s000lbl.pdf,INHIBITOR,Tclin,Homo sapiens,HGNC:12825
entrectinib,5345,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.85,,IC50,Inhibition of FAK (unknown origin) in presence of gamma33-ATP,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:9611
golodirsen,5357,exon 53 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,,,,Mechanism of Action,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211970s000lbl.pdf,ANTISENSE INHIBITOR,Tclin,Homo sapiens,HGNC:2928
brilliant Blue G,5359,Alpha-synuclein,Transporter,P37840,SNCA,SYUA_HUMAN,5.27,,IC50,Inhibition of wild type alpha-synuclein (unknown origin) aggregation expressed in Escherichia coli BL21 after 30 days by thioflavin T staining-based spectrofluorimetric analysis,CHEMBL,=,,,,,,Tchem,Homo sapiens,HGNC:11138
oliceridine,5406,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.44,,IC50,Inhibition of human Cav 1.2 ion channel expressed in HEK293 cells by whole-cell patch clamp technique,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1390
oliceridine,5406,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.44,,IC50,Inhibition of human Cav 1.2 ion channel expressed in HEK293 cells by whole-cell patch clamp technique,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:1390
viltolarsen,5408,exon 53 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,8.33,,EC50,Activity determined in rhabdomyosarcoma cells isolated from DMD patients,DRUG LABEL,=,1.0,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/212154Orig1s000PharmR.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212154Orig1s000lbl.pdf,BINDING AGENT,Tclin,Homo sapiens,HGNC:2928
tirbanibulin,5431,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,4.34,,IC50,Low affinity is expected because the peptide substrate binding site is not well formed when Src is isolated.,IUPHAR,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
tirbanibulin,5431,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,4.34,,IC50,Low affinity is expected because the peptide substrate binding site is not well formed when Src is isolated.,IUPHAR,=,,,,,INHIBITOR,Tclin,Homo sapiens,HGNC:11283
casimersen,5443,exon 53 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,,,,Mechanism of Action,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213026lbl.pdf,ANTISENSE INHIBITOR,Tclin,Homo sapiens,HGNC:2928
infigratinib,5459,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.53,,IC50,Inhibition of SRC-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
infigratinib,5459,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.53,,IC50,Inhibition of SRC-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
infigratinib,5459,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.53,,IC50,Inhibition of SRC-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct,CHEMBL,=,,,,,,Tclin,Homo sapiens,HGNC:11283
